Novo Nordisk Net Worth 2006-2021 | NVO

Interactive chart of historical net worth (market cap) for Novo Nordisk (NVO) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Novo Nordisk net worth as of September 17, 2021 is $241.08B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $241.084B $19.449B
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $434.939B 18.10
Roche Holding AG (RHHBY) Switzerland $319.781B 0.00
Pfizer (PFE) United States $249.329B 14.16
Eli Lilly (LLY) United States $221.573B 28.77
AbbVie (ABBV) United States $190.996B 9.15
Novartis AG (NVS) Switzerland $188.736B 14.02
Merck (MRK) United States $182.183B 12.47
AstraZeneca (AZN) United Kingdom $175.360B 24.93
Sanofi (SNY) $121.515B 13.39
GlaxoSmithKline (GSK) United Kingdom $105.307B 13.21
Bayer (BAYRY) Germany $52.972B 7.13
H Lundbeck (HLUYY) Denmark $5.383B 10.32
Innoviva (INVA) United States $1.059B 5.69